Position in AMGN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$9,808,020
+$2,167,950 QoQ
Shares Held
27,085
+24.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#551
of 3,140 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Global X Japan Co., Ltd. holds $85,923,287 across 8 Drug Manufacturers - General names. AMGN ranks #3 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
119,340 | $30,030,717 | |
| 2 | JNJ |
Johnson & Johnson
|
83,998 | $21,332,972 | |
| 3 | AMGN |
Amgen Inc
This page
|
27,085 | $9,808,020 | |
| 4 | MRK |
Merck & Co., Inc.
|
73,680 | $9,467,880 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
60,937 | $7,698,780 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
90,137 | $5,193,693 | |
| 7 | LLY |
ELI LILLY & Co
|
1,974 | $2,367,675 | |
| 8 | BIIB |
Biogen Inc.
|
109 | $23,550 |
All Filings in AMGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,808,020 | 27,085 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $7,640,070 | 21,714 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $6,803,792 | 20,787 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $1,324,364 | 4,693 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $23,174 | 83 | Shares | Sole | 2025-07-11 | |
| No filing history on record for this holder in this stock. | ||||||